Each month the eanNews editorial team reviews the scientific press for recently published papers of outstanding interest to neurologists. Here we present our selection for June 2025.
-
-
Our summary of neurological news items the European Medicines Agency (EMA) monthly Human Medicines Newsletter. -
Paper of the MonthEAN NewsFeatured SliderResearch Papers of the Month: Phase I trial of hES cell-derived dopaminergic neurons for Parkinson’s disease / Phase I/II trial of iPS-cell-derived dopaminergic cells for Parkinson’s disease
Our papers of the month for June are two studies that suggest that transplantation of dopaminergic progenitor cells into the striatum may confer meaningful clinical benefits for patients with Parkinson’s disease. -
Each month the eanNews editorial team reviews the scientific press for recently published papers of outstanding interest to neurologists. Here we present our selection for May 2025.
-
Paper of the MonthEAN NewsFeatured Slider
Research Papers of the Month: Tolebrutinib in Nonrelapsing Secondary Progressive Multiple Sclerosis / Tolebrutinib versus Teriflunomide in Relapsing Multiple Sclerosis
Our papers of the month for May are two papers present findings from recent trials evaluating the efficacy and safety of tolebrutinib in patients with multiple sclerosis. -
AdvocacyResearch FundingEAN NewsScientific CornerTop ArticlesDraft Innovative Health Initiative (IHI) Funding Call topics related to the brain
The Innovative Health Initiative (IHI) has just published draft topic texts for its upcoming Call 11, expected to launch officially in late June 2025. -
AdvocacyResearch FundingScientific CornerTop ArticlesUpcoming Horizon Europe Funding Opportunities for Neurology Researchers (Draft Calls)
The European Commission has released draft details for Horizon Europe’s 2025 Cluster 1 – Health calls, with official publication expected on 22 May 2025. These calls include several funding opportunities of high relevance to the neurology research community. -
Our summary of neurological news items the European Medicines Agency (EMA) monthly Human Medicines Newsletter.
-
The EAN was asked by a media outlet to provide comment on the possible role of creatine in the prevention of Alzheimer’s disease, the subject of much recent internet speculation. -
EAN NewsResearchEU Commission approves Leqembi (Lecanemab) for treatment of early-stage Alzheimer’s disease
Following an earlier decision by the EMA, the EU Commission has granted EU authorisation for Lecanemab to treat mild cognitive impairment in the early stages of Alzheimer’s disease. -
Each month the eanNews editorial team reviews the scientific press for recently published papers of outstanding interest to neurologists. Here we present our selection for April 2025.
-
Paper of the MonthEAN NewsResearchFeatured Slider
Research Paper of the Month: Intake of Red Meat in Relation to Dementia Risk and Cognitive Function in US Adults
Our Paper of the Month is a prospective cohort study conducted in the US, including participants from the Nurses’ Health Study (NHS) and the Health Professionals Follow-Up Study (HPFS). -
Our summary of neurological news items the European Medicines Agency (EMA) monthly Human Medicines Newsletter.
-
Paper of the MonthInterviewsTop ArticlesVideo Interview: Mood Alterations in the Prodromal Phase of Sporadic Creutzfeldt-Jakob Disease, with Raphael Wurm
EAN Website Editor, Letizia Leocani, talks to Raphael Wurm, lead author of the eanNews Paper of the Month for January 2025, 'Mood Alterations in the Prodromal Phase of Sporadic Creutzfeldt-Jakob Disease' -
Each month the eanNews editorial team reviews the scientific press for recently published papers of outstanding interest to neurologists. Here we present our selection for March 2025.
Newer Posts